Business

Announcement on Voluntary Disclosure of Obtaining Notice on Acceptance of Drug Clinical Trial Application for FZ-P001 Sodium for Injection for Intraoperative Visualization of Malignant Lesions in Cancer

Announcement on Voluntary Disclosure of Obtaining Notice on Acceptance of Drug Clinical Trial Application for FZ-P001 Sodium for Injection for Intraoperative Visualization of Malignant Lesions in Cancer

articleShanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class AJune 16, 20253/news/announcement-on-voluntary-disclosure-of-obtaining-notice-on-acceptance-of-drug-clinical-trial-application-for-fz-p001-sodium-for-injection-for-intraoperative-visualization-of-malignant-lesions-in-cancer
Announcement on Voluntary Disclosure of Obtaining Notice on Acceptance of Drug Clinical Trial Application for FZ-P001 Sodium for Injection for Intraoperative Visualization of Malignant Lesions in Cancer

About this update from Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class A

Announcement on Voluntary Disclosure of Obtaining Notice on Acceptance of Drug Clinical Trial Application for FZ-P001 Sodium for Injection for Intraoperative Visualization of Malignant Lesions in CancerThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class A